Lyell Immunopharma, Inc. (LYEL)

23.30 -0.80 (-3.32%) USD  |  NASDAQ  |  Mar 03, 13:46
More

Lyell Immunopharma Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade